Company profile for Akorn Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Akorn Inc. is niche generic pharmaceutical company engaged in development, manufacture and marketing of pharmaceuticals like Ophthalmologic Solutions, Ointments, Gels and Injectables, Injectables like Antidotes,Anti-infectives & Controlled substances.Akorn has its US-FDA approved manufacturing facilities at Decatur and Somerset in USA and R&D Centre at Vernon Hills, USA.Akorn India Private Limited is a leading Global Sterile ...
Akorn Inc. is niche generic pharmaceutical company engaged in development, manufacture and marketing of pharmaceuticals like Ophthalmologic Solutions, Ointments, Gels and Injectables, Injectables like Antidotes,Anti-infectives & Controlled substances.Akorn has its US-FDA approved manufacturing facilities at Decatur and Somerset in USA and R&D Centre at Vernon Hills, USA.Akorn India Private Limited is a leading Global Sterile Contract Manufacturer spread over 60,000 sq. meters with 5 dedicated blocks for Cephalosporins, Carbapenems, Hormones, General liquid fill sterile Injectables.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1925 W. Field Court, Suite 300, Lake Forest, Illinois 60045
Telephone
Telephone
1-800-932-5676
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/akorn-pharmaceuticals-bankruptcy-recalls-cause-lead-poisoning-drug-shortage/

Tyler Patchen ENDPTS
27 Jul 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215768

FDA
09 Jun 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

FDA
07 Jun 2023

https://www.prnewswire.com/news-releases/akorn-issues-voluntary-nationwide-recall-of-various-human-and-animal-drug-products-within-expiry-due-to-company-shutdown-301815349.html

BUSINESSWIRE
03 May 2023

https://www.prnewswire.com/news-releases/thea-pharma-inc-statement-related-to-akorns-voluntary-nationwide-recall-of-various-human-and-animal-drug-branded-ophthalmic-products-within-expiry-due-to-company-shutdown-301811331.html

PR NEWSWIRE
28 Apr 2023

https://endpts.com/after-akorns-site-closures-in-the-us-albuterol-remains-in-shortage/

Tyler Patchen ENDPTS
31 Mar 2023

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty